Medical devices incorporating functional adhesives
원문보기
IPC분류정보
국가/구분
United States(US) Patent
등록
국제특허분류(IPC7판)
A61B-017/08
A61B-017/00
A61B-017/34
A61L-029/14
A61B-017/02
A61F-002/00
출원번호
US-0309930
(2014-06-20)
등록번호
US-9554782
(2017-01-31)
발명자
/ 주소
Hadba, Ahmad Robert
Kennedy, Jack
Ladet, Sèbastien
출원인 / 주소
Covidien LP
인용정보
피인용 횟수 :
0인용 특허 :
54
초록▼
A method for treating a wound or defect at a surgical target site using a minimally invasive surgical procedure is provided which includes utilizing a surgical access device such as a port or a catheter having a plurality of reactive members of a specific binding pair releasably contained on a surfa
A method for treating a wound or defect at a surgical target site using a minimally invasive surgical procedure is provided which includes utilizing a surgical access device such as a port or a catheter having a plurality of reactive members of a specific binding pair releasably contained on a surface of the access device, the reactive members having affinity for binding a cellular component of tissue cells located at the target site; contacting the surface of the access device with the tissue cells, wherein upon contact of the reactive members on the surface of the access device with the tissue cells, the reactive members are released from the surface of the access device and bind to the tissue; providing a tissue repair member having secured thereto a plurality of complementary reactive members of the specific binding pair; and applying the tissue repair member to the tissue, wherein upon contact of the complementary reactive members on the surface of the tissue repair member with the reactive members on the tissue, covalent bonds are formed between the reactive members and the complementary reactive members, thus bonding the tissue repair member to the tissue. A surgical access device for use in minimally invasive surgery is provided which includes a plurality of reactive members of a specific binding pair releasably contained on a surface of the access device, the reactive members having an affinity for binding a cellular component of tissue cells and another affinity for binding complementary members of the specific binding pair.
대표청구항▼
1. A method for treating a wound or defect at a target site using a minimally invasive surgical procedure comprising: providing a surgical access device having a plurality of reactive members of a specific binding pair releasably contained on an exterior surface of the access device, the reactive me
1. A method for treating a wound or defect at a target site using a minimally invasive surgical procedure comprising: providing a surgical access device having a plurality of reactive members of a specific binding pair releasably contained on an exterior surface of the access device, the reactive members having affinity for binding a cellular component of tissue cells located at the target site;contacting the exterior surface of the access device with the tissue cells, wherein upon contact of the reactive members on the surface of the access device with the tissue cells, the reactive members are released from the exterior surface of the access device and bind to the tissue cells;providing a tissue repair member having secured thereto a plurality of complementary reactive members of the specific binding pair; andapplying the tissue repair member to the tissue cells, wherein upon contact of the complementary reactive members on the surface of the tissue repair member with the reactive members on the tissue cells, covalent bonds are formed between the reactive members and the complementary reactive members, thus bonding the tissue repair member to the target site. 2. The method for treating a wound or defect at a target site using a minimally invasive surgical procedure according to claim 1 wherein the reactive members and the complementary reactive members of the specific binding pair bind to one another via a reaction selected from the group consisting of Huisgen cycloaddition reaction, a Diels-Alder reaction and a thiol-ene reaction. 3. The method for treating a wound or defect at a target site using a minimally invasive surgical procedure according to claim 2 wherein the reactive and the complementary reactive members of the specific binding pair are alkynes and azides. 4. The method for treating a wound or defect at a target site using a minimally invasive surgical procedure according to claim 3 wherein the reactive members are alkynes and the complementary reactive members are azides. 5. The method for treating a wound or defect at a target site using a minimally invasive surgical procedure according to claim 4 wherein the reactive and complementary reactive members of the specific binding pair are dienes and alkenes. 6. The method for treating a wound or defect at a target site using a minimally invasive surgical procedure according to claim 3 wherein the reactive members are azides and the complementary reactive members are alkynes. 7. The method for treating a wound or defect at a target site using a minimally invasive surgical procedure according to claim 2 wherein the reaction is catalyzed by copper to activate an alkyne and an azide for [3+2] cycloaddition. 8. The method for treating a wound or defect at a target site using a minimally invasive surgical procedure according to claim 2 wherein the reaction involves a cyclooctyne reagent and an azide for [3+2] cycloaddition. 9. The method for treating a wound or defect at a target site using a minimally invasive surgical procedure according to claim 2 wherein the reactive and complementary reactive members of the specific binding pair are thiols and alkenes. 10. The method for treating a wound or defect at a target site using a minimally invasive surgical procedure according to claim 2 wherein the complementary reactive members of the specific binding pair are secured to the tissue repair member by surface modification techniques selected from the group consisting of plasma treatment, silane coupling treatment and acid sensitization. 11. The method for treating a wound or defect at a target site using a minimally invasive surgical procedure according to claim 1 wherein a rapidly disintegrating coating on the exterior surface of the access device causes release of the reactive members of a specific binding pair. 12. The method for treating a wound or defect at a target site using a minimally invasive surgical procedure according to claim 11 wherein the rapidly disintegrating coating is made from a compound selected from the group consisting of sugar, poly(ethylene glycol), polyvinylpyrrolidone, poly(vinyl alcohol), hydroxypropyl cellulose, hydroxymethyl cellulose, hydroxypropyl methylcellulose, gelatin and combinations thereof. 13. The method for treating a wound or defect at a target site using a minimally invasive surgical procedure according to claim 1 wherein the surgical access device is a port or catheter. 14. The method for treating a wound or defect at a target site using a minimally invasive surgical procedure according to claim 1 wherein the reactive members are conjugated to a linker adapted to link the reactive members to the tissue cells. 15. The method for treating a wound or defect at a target site using a minimally invasive surgical procedure to claim 14 wherein the reactive members bind to the tissue cells via an RGD linker. 16. The method for treating a wound or defect at a target site using a minimally invasive surgical procedure according to claim 14 wherein the reactive members bind to the tissue cells via a ligand-receptor linkage. 17. The method for treating a wound or defect at a target site using a minimally invasive surgical procedure according to claim 16 wherein the ligand-receptor linkage is selected from the group consisting of antibody-antigen, biotin-avidin and biotin-streptavidin. 18. The method for treating a wound or defect at a target site using a minimally invasive surgical procedure according to claim 17 wherein the reactive members are conjugated to a linker selected from the group consisting of antibody, Fab, F(ab')2, Fv, single chain antibody (SCA) and single complementary-determining region (CDR). 19. The method for treating a wound or defect at a target site using a minimally invasive surgical procedure according to claim 16 wherein the ligand binds to a receptor selected from the group consisting of peptides, oligosaccharides, oligonucleotides and lipids. 20. The method for treating a wound or defect at a target site using a minimally invasive surgical procedure according to claim 14 wherein the linker is degraded by hydrolysis or enzymatic action. 21. The method for treating a wound or defect at a target site using a minimally invasive surgical procedure according to claim 1 wherein the tissue repair member is a patch, scaffold, matrix, plug or mesh. 22. The method for treating a wound or defect at a target site using a minimally invasive surgical procedure according to claim 21 wherein the tissue repair member is made of foam, woven material and non-woven material. 23. The method for treating a wound or defect at a target site using a minimally invasive surgical procedure to claim 1 wherein the tissue repair member is made of a polymer selected from the group consisting of polycarbonates, polyolefins, polymethacrylates, polystyrenes, polyamides, polyurethanes, poly(ethylene terephthalate), poly(lactic acid), poly(glycolic acid), polyhydroxbutyrate, dioxanones (e.g., 1,4-dioxanone), [delta]-valerolactone, 1,dioxepanones (e.g., 1,4-dioxepan-2-one and 1,5-dioxepan-2-one), poly(phosphazine), polyesters, poly(ethylene glycol, polyethylene oxides), polyacrylamides, cellulose esters, fluoropolymers, vinyl polymers, silk, collagen, alginate, chitin, chitosan, hyaluronic acid, chondroitin sulfate, poly(hydroxyethyl methacrylate), polyvinylpyrrolidone, poly(vinyl alcohol), poly(acrylic acid), polyacetate, polycaprolactone, polypropylene, glycerols, poly(amino acids), copoly(ether-esters), poly(alkylene oxides), polyamides, poly(iminocarbonates), poly(alkylene oxalates), polyoxaesters, polyorthoesters, polyphosphazenes, polypeptides and copolymers, block copolymers, homopolymers, blends and combinations thereof.
연구과제 타임라인
LOADING...
LOADING...
LOADING...
LOADING...
LOADING...
이 특허에 인용된 특허 (54)
Paul O. Zamora ; Shigemasa Osaki ; Ray Tsang, Amphipathic coating for modulating cellular adhesion composition and methods.
Rowe Stephen C. (Wellesley MA) Hubbell Jeffrey A. (San Marino CA) Herman Stephen J. (Andover MA) Sun Vae (Palo Alto CA) Lang Michael F. (North Andover MA) Selecman George E. (Marblehead MA) Ahari Fre, Apparatus and method for local application of polymeric material to tissue.
Bennett Steven L. (Southington CT) Jiang Ying (North Haven CT) Gruskin Elliott A. (Killingworth CT) Connolly Kevin M. (Hamden CT), Bioabsorbable branched polymers containing units derived from dioxanone and medical/surgical devices manufactured theref.
Ragheb, Anthony O.; Bates, Brian L.; Fearnot, Neal E.; Kozma, Thomas G.; Voorhees, III, William D.; Gershlick, Anthony H., Coated implantable medical device.
Fran.cedilla.ois Regis Ory FR; Michel Therin FR; Philippe Gravagna FR; Jean-Louis Tayot FR, Composite prosthesis for preventing post-surgical adhesions and method for obtaining same.
Tomalia, Donald A.; Swanson, Douglas R.; Huang, Baohua; Pulgam, Veera Reddy, Dendritic polymers with enhanced amplification and interior functionality.
Tomalia, Donald A.; Swanson, Douglas R.; Huang, Baohua; Pulgam, Veera Reddy; Heinzelmann, Joseph R.; Svenson, Sonke; Reyna, Lori A.; Zhuravel, Michael A.; Chauhan, Abhay Singh; DeMattei, Cordell R., Dendritic polymers with enhanced amplification and interior functionality.
Spehar Edward R. (49 Orion Way Neshanic Station NJ 08853) Harkins Bernard F. (2000 Woodland Ave. S. Plainfield NJ 07080) Colin Laurence (Box 301 Cross River NY 10518), Dispensing mixer for the storage and mixing of separate materials.
Tiefenbrun Jonathan (62 Country Rd. Mamaronek NY 10543) Wilk Peter J. (185 W. End Ave. New York NY 10023), Instrument and associated method for applying biologically effective composition during laparoscopic operation.
Yan Mingdi ; Keana John F. W. ; Karapetrov Goran ; Sevrain Christopher J-P ; Wybourne Martin N., Methods for functionalizing and coating substrates and devices made according to the methods.
Pittalis Francesco (Rome ITX) Bartoli Francesco (Rome ITX) Giovannoni Guido (S. Giuliano Milanese ITX), Process for the preparation of chitosan fibers.
Zuccato Alessandro,ITX ; Cella Gian Domenico,ITX ; Perego Gabriele,ITX, Process of surface activation of biocompatible and bioabsorbable aliphatic polyesters and polyesters thus activated.
Wallace Donald G. ; Cruise Gregory M. ; Rhee Woonza M. ; Schroeder Jacqueline Anne ; Coker ; III George T. ; Maroney Marcee M., Rapid gelling biocompatible polymer composition.
Wallace, Donald G.; Cruise, Gregory M.; Rhee, Woonza M.; Schroeder, Jacqueline Anne; Coker, III, George T.; Maroney, Marcee M.; Trollsas, Olof Mikael, Rapid-gelling biocompatible polymer composition and associated methods of preparation and use.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.